BOOTHBAY FUND MANAGEMENT, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2023$92,261
-51.0%
17,880
-50.0%
0.00%
-50.0%
Q1 2023$188,455
+87.5%
35,7600.0%0.00%
+100.0%
Q4 2022$100,486
-49.0%
35,760
-24.5%
0.00%
-60.0%
Q3 2022$197,000
-78.4%
47,381
-48.0%
0.01%
-80.0%
Q3 2021$912,000
-50.2%
91,166
-29.5%
0.02%
-57.6%
Q2 2021$1,832,000
+164.7%
129,225
+206.4%
0.06%
+126.9%
Q1 2021$692,000
-51.4%
42,177
-38.7%
0.03%
-50.9%
Q4 2020$1,425,000
+9.0%
68,846
-59.9%
0.05%
-32.9%
Q3 2020$1,307,000
-37.4%
171,735
-31.5%
0.08%
-44.8%
Q2 2020$2,088,000
+127.0%
250,712
+34.8%
0.14%
+88.2%
Q1 2020$920,000
+161.4%
185,949
+108.8%
0.08%
+145.2%
Q4 2019$352,000
+28.0%
89,077
-1.6%
0.03%
+24.0%
Q3 2019$275,000
+276.7%
90,527
+446.6%
0.02%
+257.1%
Q2 2019$73,000
-85.5%
16,561
-69.4%
0.01%
-93.3%
Q2 2017$502,00054,2000.10%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 5,618,861$116,310,000100.00%
Opaleye Management Inc. 6,510,000$134,758,00017.60%
DELTEC ASSET MANAGEMENT LLC 2,168,573$44,889,0006.87%
Versant Venture Management, LLC 1,465,384$30,333,0003.15%
GREAT POINT PARTNERS LLC 856,162$17,723,0002.88%
Affinity Asset Advisors, LLC 220,000$4,554,0002.41%
Altium Capital Management LP 303,174$6,276,0002.34%
Endurant Capital Management LP 290,465$6,013,0002.17%
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 50,396$1,043,0001.17%
Lisanti Capital Growth, LLC 366,040$7,577,0001.05%
View complete list of OCULAR THERAPEUTIX INC shareholders